Text Size:   A+ A- A   •   Text Only
Find     
Site Image

DHS news release

Jan. 20, 2006

 

Contact: Bonnie Widerburg (971) 673-1282
Technical contact: Dave Stone (971) 673-0444


Public meeting notice: Biopharming Ad Hoc Committee meets Jan. 23

 



What: Biopharming Ad Hoc Committee meeting.

 

When: 1 p.m. to 3 p.m. on Monday, Jan. 23.


Where: Portland State Office Building, Room 918, Portland.


Agenda: A review of technical papers on various biopharming topics including biotech potential, Colorado's experience, a USDA audit of biotech regulation and a briefing on state and federal law and genetically modified foods. Joseph Cortright, economist and president of Impressa Consulting in Portland, will present his view of biopharming and biotechnology's potential impact on Oregon's economy. Neil Hoffman, Ph.D., U.S. Department of Agriculture director of the Environmental Risk Analysis Division in Biotechnology Regulatory Services, will discuss procedures for approval of biopharmaceutical permits.


Background: The governor and the state senate in 2005 charged the Oregon departments of Agriculture and Human Services to convene a Biopharming Ad Hoc Committee to develop a consensus policy recommendation to the governor regarding biopharmaceuticals produced in human food or animal feed crops.


Biopharming is the production of pharmaceutical proteins or other materials in genetically engineered plants and animals.


The committee has 10 standing members and is chaired by Jim Rue, State Board of Agriculture, with Keith Harcourt, Public Health Advisory Board, serving as vice-chair. The State Board of Agriculture and the Public Health Advisory Board are equally represented, along with two independent scientists and two non-voting ex-officio members representing the Oregon Department of Agriculture and Department of Human Services.


Future meetings will be held monthly, with the location of meetings to alternate between Portland and Salem.